Utah Code § 58-37-4.2

Current through the 2024 Fourth Special Session

Section 58-37-4.2 - Listed controlled substances

The following substances, their analogs, homologs, and synthetic equivalents are listed controlled substances:

(1) AB-001;

(2) AB-PINACA; N-[1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole-3-carboxamide;

(3) AB-FUBINACA; N-[1-(aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl) methyl]-1H-indazole-3-carboxamide;

(4) AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide);

(5) ADB-CHMINACA (N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1- (cyclohexylmethyl)indazole-3-carboxamide);

(6) ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1oxobutan-2-yl)-1- (4-fluorobenzyl)-1H-indazole-3-caboxamide);

(7) AKB48;

(8) alpha-Pyrrolidinohexanophenone (alpha-PHP) (1-Phenyl-2-(pyrrolidin-1-yl)hexan-1-one);

(9) alpha-Pyrrolidinovalerophenone (alpha-PVP);

(10) AM-694 (1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone);

(11) AM-1248;

(12) AM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole);

(13) AM-2233;

(14) AM-679;

(15) A796,260;

(16) Butylone;

(17) CP 47,497 and its C6, C8, and C9 homologs (2-[(1R,3S)-3-hydroxycyclohexyl] -5-(2-methyloctan-2-yl)phenol);

(18) Diisopropyltryptamine (DiPT);

(19) Ethylone;

(20) Ethylphenidate;

(21) Fluoroisocathinone;

(22) Fluoromethamphetamine;

(23) Fluoromethcathinone;

(24) FUB-AMB; methyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)valinate;

(25) HU-210; (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl) -6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;

(26) HU-211; Dexanabinol,(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;

(27) JWH-015; (2-methyl-1-propyl-1H-indol-3-yl)-1-naphthalenyl-methanone;

(28) JWH-018; Naphthalen-1-yl-(pentylindol-3-yl)methanone {also known as 1-Pentyl-3-(1-naphthoyl)indole};

(29) JWH-019; 1-hexyl-3-(1-naphthoyl)indole;

(30) JWH-073; Naphthalen-1-yl(1-butylindol-3-yl)methanone {also known as 1-Butyl-3-(1-naphthoyl)indole};

(31) JWH-081; 4-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone;

(32) JWH-122; CAS#619294-47-2; (1-Pentyl-3-(4-methyl-1-naphthoyl)indole);

(33) JWH-200; 1-(2-(4-(morpholinyl)ethyl))-3-(1-naphthoyl)indole;

(34) JWH-203; 1-pentyl-3-(2-chlorophenylacetyl)indole;

(35) JWH-210; 4-ethyl-1-naphthalenyl(1-pentyl-1H-indol-3-yl)-methanone;

(36) JWH-250; 1-pentyl-3-(2-methoxyphenylacetyl)indole;

(37) JWH-251; 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone;

(38) JWH-398; 1-pentyl-3-(4-chloro-1-naphthoyl)indole;

(39) MAM-2201;

(40) MAM-2201; (1-(5-fluoropentyl)-1H-indol-3-yl)(4-ethyl-1-naphthalenyl)-methanone;

(41) Methoxetamine;

(42) Naphyrone;

(43) PB-22; 1-pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester;

(44) Pentedrone;

(45) Pentylone;

(46) RCS-4; 1-pentyl-3-(4-methoxybenzoyl)indole;

(47) RCS-8; 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole {also known as BTW-8 and SR-18};

(48) STS-135;

(49) UR-144;

(50) UR-144 N-(5-chloropentyl) analog;

(51) XLR11;

(52) 2C-C;

(53) 2C-D;

(54) 2C-E;

(55) 2C-H;

(56) 2C-I;

(57) 2C-N;

(58) 2C-P;

(59) 2C-T-2;

(60) 2C-T-4;

(61) 2NE1;

(62) 25I-NBOMe;

(63) 2,5-Dimethoxy-4-chloroamphetamine (DOC);

(64) 4-Fluoro MDMB-BUTINACA (Methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate);

(65) 4-methylmethcathinone {also known as mephedrone};

(66) 3,4-methylenedioxypyrovalerone {also known as MDPV};

(67) 3,4-Methylenedioxymethcathinone {also known as methylone};

(68) 4-methoxymethcathinone;

(69) 4-Methyl-alpha-pyrrolidinopropiophenone;

(70) 4-Methylethcathinone;

(71) 5F-AKB48; 1-(5-flouropentyl)-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3- carboxamide;

(72) 5-Fluoro ADB (Methyl N-{[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl}-3-methyl-valinate);

(73) 5-Fluoro AMB (Methyl N-{[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl}valinate);

(74) 5-fluoro-PB-22; 1-(5-fluoropentyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester;

(75) 5-Iodo-2-aminoindane (5-IAI);

(76) 5-MeO-DALT;

(77) 25B-NBOMe; 2-(r-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine;

(78) 25C-NBOMe; 2-(4Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine; and

(79) 25H-NBOMe; 2-(2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine.

Utah Code § 58-37-4.2

Amended by Chapter 26, 2020 General Session ,§ 1, eff. 5/12/2020.

Amended by Chapter 146, 2018 General Session ,§ 2, eff. 5/8/2018.

Amended by Chapter 172, 2017 General Session ,§ 2, eff. 3/21/2017.

Amended by Chapter 23, 2014 General Session ,§ 1, eff. 3/20/2014.

Amended by Chapter 88, 2013 General Session ,§ 2, eff. 5/14/2013.

Amended by Chapter 83, 2013 General Session ,§ 2, eff. 5/14/2013.

Amended by Chapter 297, 2012 General Session ,§ 3, eff. 5/8/2012.

Enacted by Chapter 12, 2011 General Session